CN108477342A - A kind of fat reducing decompression chrysanthemum tea and preparation method thereof - Google Patents
A kind of fat reducing decompression chrysanthemum tea and preparation method thereof Download PDFInfo
- Publication number
- CN108477342A CN108477342A CN201810286564.4A CN201810286564A CN108477342A CN 108477342 A CN108477342 A CN 108477342A CN 201810286564 A CN201810286564 A CN 201810286564A CN 108477342 A CN108477342 A CN 108477342A
- Authority
- CN
- China
- Prior art keywords
- parts
- chrysanthemum
- fat reducing
- chrysanthemum tea
- tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of fat reducing decompression chrysanthemum tea of present invention offer and preparation method thereof, is related to chrysanthemum tea technical field.The present invention is made of following raw material:Chrysanthemum, ginkgo biloba p.e, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry.Fat reducing decompression chrysanthemum tea of the present invention combines the function and one of health care and tea, it can not only improve and adjust the metabolism of skin histology, inhibit the rising of blood glucose, also there are the health-care efficacies such as clearing heat and moistening lung, the sore that disappears nti-freckle, eliminating inflammation and expelling toxin, decompression fat reducing, dispelling fatigue, drunk extensively suitable for various crowds.
Description
Technical field
The present invention relates to chrysanthemum tea technical fields, and in particular to a kind of fat reducing decompression chrysanthemum tea and preparation method thereof.
Background technology
Chrysanthemum is the perennial herb plant of composite family, Chrysanthemum in Plant Taxonomy.It is divided into bull by planting form
Chrysanthemum, the solely cultivated forms such as this chrysanthemum, Chrysanthemum morifolium Ramat, cliff chrysanthemum, skill chrysanthemum, Desk Chrysanthemum Applying;Have and is divided into garden armful by the mode of appearance of petal, moves back
Embrace, it is anti-embrace, disorderly embrace, the dew heart is embraced, flies the noon cultivated forms such as embraces.Chrysanthemum in different type names various kind names again
Claim.Chrysanthemum is one of the 10 famous flowers of China, one of four gentlemen flowers (plum blossom, orchid, bamboo and chrysanthemum) and the four cut-flowers in the world (chrysanthemum, the moon
One of season, carnation, gladiolus), yield tops the list.Because chrysanthemum has the character of poor proud snow, just there is " picking chrysanthemum by the east fence for TAO Yuan-ming
Under, it is long to see South Mountain " well-known phrase.Chinese have the Double Ninth Festival to admire the beauty of chrysanthemum and drink the custom of chrysanthemum wine.Tang Meng is great《Cross the old friend village:
" until in the Double Ninth Festival day, also come with regard to chrysanthemum." chrysanthemum has further been given lucky, long-lived meaning in ancient mythical legend, because it has very
High medical value.The effect of modern medicine also studies confirmation, chrysanthemum and effect:With blood pressure lowering, eliminate cancer cell, expansion hat
Shape artery and antibacterial, chrysanthemum tea gives off a strong fragrance, and refreshes the mind, it may have certain relaxation nerve, releive headache the effect of.Chrysanthemum
Expansible coronary artery increases blood flow, reduces blood pressure, to coronary heart disease, hypertension, the excessively high disease of artery sclerosis, serum cholesterol
There is fine curative effect.
Chrysanthemum is usually processed into chrysanthemum tea to be drunk for people, still, on the market without the chrysanthemum with fat reducing buck functionality
Therefore tea develops a kind of chrysanthemum tea with fat reducing buck functionality, be of great significance for people's health life.
Invention content
In view of the shortcomings of the prior art, a kind of fat reducing decompression chrysanthemum tea of present invention offer and preparation method thereof.
In order to achieve the above object, technical scheme of the present invention is achieved by the following technical programs:
A kind of fat reducing decompression chrysanthemum tea, the fat reducing decompression chrysanthemum tea are made of the raw material of following parts by weight:Chrysanthemum 30-60
Part, 20-37 parts of ginkgo biloba p.e, 12-20 parts of uncaria, 10-25 parts of the fruit of Chinese wolfberry, 15-25 parts of Fructus Corni, 10-25 parts of Rhizoma Atractylodis Macrocephalae, Pueraria lobota
15-27 parts of root, 10-17 parts of the root bark of white mulberry.
Further, the fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:35-55 parts of chrysanthemum, ginkgo leaf
24-32 parts of extract, 15-18 parts of uncaria, 15-21 parts of the fruit of Chinese wolfberry, 18-22 parts of Fructus Corni, 14-22 parts of Rhizoma Atractylodis Macrocephalae, pueraria lobata 19-25
Part, 12-15 parts of the root bark of white mulberry.
Further, the fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:45 parts of chrysanthemum, ginkgo leaf extraction
28 parts of object, 16 parts of uncaria, 17 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, 18 parts of Rhizoma Atractylodis Macrocephalae, 21 parts of pueraria lobata, 14 parts of the root bark of white mulberry.
Further, the fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:40 parts of chrysanthemum, ginkgo leaf extraction
23 parts of object, 14 parts of uncaria, 24 parts of the fruit of Chinese wolfberry, 23 parts of Fructus Corni, 24 parts of Rhizoma Atractylodis Macrocephalae, 22 parts of pueraria lobata, 16 parts of the root bark of white mulberry.
Further, the extracting method of the ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, mistake
40-100 mesh sieves, and Ginkgo Leaf 2g is tested in round-bottomed flask, and the 50ml mixing of 60-68% ethanol solutions, 60- is added
Refluxing extraction 2-3h under 65 DEG C of water-baths, is filtered while hot, and filter residue carries out second extraction, is collected filtrate, is later 70- with volume fraction
75% ethanol solution washing residue simultaneously filter, merge 3 filtrates, by filtrate under 50-55 DEG C of water-bath spin concentration, obtain silver
Apricot leaf extract.
A kind of production method of fat reducing decompression chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1-2h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, standby
With;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can.
Further, sterilization described in step S3 is sterilization 1-2h under ozonizer.
The mechanism of action of ingredient in raw material:
Ginkgo biloba p.e:The medical value of ginkgo biloba p.e and application are extremely wide, in anti-inflammatory, antiallergy, expansion
Blood vessel, protection cardiovascular and cerebrovascular improve peripheral blood circulation, reduce serum cholesterol and anticancer adjuvant etc. performance drug effect, can
To be widely used in the prevention and health care of the systemic diseases such as cardiovascular and cerebrovascular, nerve;Ginkgo biloba p.e can mitigate blood courage simultaneously
Sterol, triacylglycerol, very low density lipoprotein mitigate blood fat, improve microcirculation, inhibit blood coagulation to the adverse effect of human body, this
It is notable to the therapeutic effect of hypertension a bit.
The fruit of Chinese wolfberry:The fruit of Chinese wolfberry contains sweet tea benzene alkali, polysaccharides, Liang Mus pavilion, free amino acid, vitamin and lot of trace member
Element.Main pharmacological has:The fruit of Chinese wolfberry has significantly hypoglycemic effect, can repair the regeneration of impaired B cell.The fruit of Chinese wolfberry
Extract can reduce rat blood sugar, increase sugar tolerance, this is related with the derivative contained in the fruit of Chinese wolfberry.Polysaccharides can reduce just
Normal animal blood glucose has apparent prevention effect to animal diabetes caused by alloxan.In addition, polysaccharides is to phlorose
Glycosides has stronger non-competitive inhibition.
Fructus Corni:Fructus Corni main component has cornin, morroniside, loganin, river deer tooth Zhu glycosides, the new glycosides of Fructus Corni, goes back
There are tannin, ursolic acid, gallic acid, malic acid, oleanolic acid, tartaric acid and vitamin A.Main pharmacological:Resisting stress resists
Oxidation, reducing blood lipid.Fructus Corni can enhance the anti-stress ability of body, improve anti-fatigue ability, enhance memory.It can improve red thin
SOD activity in born of the same parents, to anti peroxidation of lipid.Its alcohol extract also has the effect of reducing blood lipid, can reduce serum triglyceride, cholesterol
Content, have anti arteriosclerosis effect;Hypoglycemic and anti-diabetic vascular lesion.Fructus Corni hypoglycemic effect is apparent, mountain Zhu
Cornel energy is hypoglycemic, inhibits platelet aggregation, reduces blood viscosity, confrontation peroxide injury, the painstaking effort for mitigating diabetic
Pipe damages.
A kind of fat reducing decompression chrysanthemum tea of present invention offer and preparation method thereof, advantage is compared with prior art:
Fat reducing decompression chrysanthemum tea of the present invention combines the function and one of health care and tea, can not only improve and adjust skin
The metabolism of tissue inhibits the rising of blood glucose, also has clearing heat and moistening lung, the sore that disappears nti-freckle, eliminating inflammation and expelling toxin, decompression fat reducing, eliminates
The health-care efficacies such as fatigue are drunk suitable for various crowds extensively;
Fat reducing decompression chrysanthemum tea production method of the present invention is simple and practicable, is suitble to industrialized production, raw material is using chrysanthemum, ginkgo
Leaf extract, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry, mating reaction between raw material reduce blood viscosity, adjust
Microcirculation is saved, organ function is adjusted, adjusts equilibrium between yin and yang, reach nourishing liver and kidney, the effect of improving eyesight of promoting the production of body fluid, hypoglycemic, reducing blood lipid,
Merge eye disease, hyperlipidemia to being suitable for diabetes, at the same have concurrently treatment have a dizzy spell, soreness and weakness of waist and knees, hypopsia, two it is dry
Puckery, blurring of vision effect.
Specific implementation mode
In order to make the object, technical scheme and advantages of the embodiment of the invention clearer, with reference to the embodiment of the present invention pair
Technical solution in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is a part of the invention
Embodiment, instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art are not making wound
The every other embodiment obtained under the premise of the property made labour, shall fall within the protection scope of the present invention.
Embodiment 1:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:30 parts of chrysanthemum, ginkgo biloba p.e 20
Part, 12 parts of uncaria, 10 parts of the fruit of Chinese wolfberry, 15 parts of Fructus Corni, 10 parts of Rhizoma Atractylodis Macrocephalae, 15 parts of pueraria lobata, 10 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, crosses 40 mesh sieve, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 60% ethanol solution 50ml mixing, refluxing extraction under 60 DEG C of water-baths is added
2h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 70% with volume fraction washs residue
And filter, merge 3 filtrates, by filtrate under 50 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, spare;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 1h under ozonizer.
Embodiment 2:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:60 parts of chrysanthemum, ginkgo biloba p.e 37
Part, 20 parts of uncaria, 25 parts of the fruit of Chinese wolfberry, 25 parts of Fructus Corni, 25 parts of Rhizoma Atractylodis Macrocephalae, 27 parts of pueraria lobata, 17 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It crushes, sieves with 100 mesh sieve after ginkgo leaf is freeze-dried, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 68% ethanol solution 50ml mixing, refluxing extraction under 65 DEG C of water-baths is added
3h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 75% with volume fraction washs residue
And filter, merge 3 filtrates, by filtrate under 55 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 2h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, spare;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 2h under ozonizer.
Embodiment 3:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:45 parts of chrysanthemum, ginkgo biloba p.e 28
Part, 16 parts of uncaria, 17 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, 18 parts of Rhizoma Atractylodis Macrocephalae, 21 parts of pueraria lobata, 14 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, crosses 70 mesh sieve, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 64% ethanol solution 50ml mixing, refluxing extraction under 62 DEG C of water-baths is added
2.5h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 73% with volume fraction washs residual
Slag simultaneously filters, merge 3 filtrates, by filtrate under 53 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1.5h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, standby
With;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 1.5h under ozonizer.
Embodiment 4:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:40 parts of chrysanthemum, ginkgo biloba p.e 23
Part, 14 parts of uncaria, 24 parts of the fruit of Chinese wolfberry, 23 parts of Fructus Corni, 24 parts of Rhizoma Atractylodis Macrocephalae, 22 parts of pueraria lobata, 16 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, crosses 50 mesh sieve, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 62% ethanol solution 50ml mixing, refluxing extraction under 61 DEG C of water-baths is added
2h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 71% with volume fraction washs residue
And filter, merge 3 filtrates, by filtrate under 51 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1.2h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, standby
With;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 1.2h under ozonizer.
Embodiment 5:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:35 parts of chrysanthemum, ginkgo biloba p.e 24
Part, 15 parts of uncaria, 15 parts of the fruit of Chinese wolfberry, 18 parts of Fructus Corni, 14 parts of Rhizoma Atractylodis Macrocephalae, 19 parts of pueraria lobata, 12 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, crosses 80 mesh sieve, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 66% ethanol solution 50ml mixing, refluxing extraction under 64 DEG C of water-baths is added
2.8h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 74% with volume fraction washs residual
Slag simultaneously filters, merge 3 filtrates, by filtrate under 54 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1.8h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, standby
With;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 1.3h under ozonizer.
Embodiment 6:
The present embodiment fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:55 parts of chrysanthemum, ginkgo biloba p.e 32
Part, 18 parts of uncaria, 21 parts of the fruit of Chinese wolfberry, 22 parts of Fructus Corni, 22 parts of Rhizoma Atractylodis Macrocephalae, 25 parts of pueraria lobata, 15 parts of the root bark of white mulberry;
Wherein, the extracting method of ginkgo biloba p.e is:It is crushed after ginkgo leaf is freeze-dried, crosses 60 mesh sieve, it will
Ginkgo Leaf 2g is tested in round-bottomed flask, and 65% ethanol solution 50ml mixing, refluxing extraction under 62 DEG C of water-baths is added
2.5h is filtered while hot, and filter residue carries out second extraction, collects filtrate, and the ethanol solution for being later 72% with volume fraction washs residual
Slag simultaneously filters, merge 3 filtrates, by filtrate under 52 DEG C of water-baths spin concentration, obtain ginkgo biloba p.e;
The production method that the present embodiment fat reducing is depressured chrysanthemum tea, includes the following steps:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for steaming
The water of kettle 2/3, boiling 1.5h are boiled, filtering obtains filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, standby
With;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization,
Small tea bag is made in whole grain, pack packaging, you can, wherein sterilization is sterilization 1.6h under ozonizer.
It should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations;Although ginseng
According to previous embodiment, invention is explained in detail, it will be understood by those of ordinary skill in the art that:It still can be with
Technical scheme described in the above embodiments is modified or equivalent replacement of some of the technical features;And
These modifications or replacements, the spirit and model of various embodiments of the present invention technical solution that it does not separate the essence of the corresponding technical solution
It encloses.
Claims (7)
1. a kind of fat reducing is depressured chrysanthemum tea, which is characterized in that the fat reducing decompression chrysanthemum tea is made of the raw material of following parts by weight:
30-60 parts of chrysanthemum, 20-37 parts of ginkgo biloba p.e, 12-20 parts of uncaria, 10-25 parts of the fruit of Chinese wolfberry, 15-25 parts of Fructus Corni, Rhizoma Atractylodis Macrocephalae
10-25 parts, 15-27 parts of pueraria lobata, 10-17 parts of the root bark of white mulberry.
2. fat reducing is depressured chrysanthemum tea according to claim 1, which is characterized in that the fat reducing is depressured chrysanthemum tea by following weight
The raw material of part is made:35-55 parts of chrysanthemum, 24-32 parts of ginkgo biloba p.e, 15-18 parts of uncaria, 15-21 parts of the fruit of Chinese wolfberry, Fructus Corni
18-22 parts, 14-22 parts of Rhizoma Atractylodis Macrocephalae, 19-25 parts of pueraria lobata, 12-15 parts of the root bark of white mulberry.
3. fat reducing is depressured chrysanthemum tea according to claim 1, which is characterized in that the fat reducing is depressured chrysanthemum tea by following weight
The raw material of part is made:45 parts of chrysanthemum, 28 parts of ginkgo biloba p.e, 16 parts of uncaria, 17 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, Rhizoma Atractylodis Macrocephalae 18
Part, 21 parts of pueraria lobata, 14 parts of the root bark of white mulberry.
4. fat reducing is depressured chrysanthemum tea according to claim 1, which is characterized in that the fat reducing is depressured chrysanthemum tea by following weight
The raw material of part is made:40 parts of chrysanthemum, 23 parts of ginkgo biloba p.e, 14 parts of uncaria, 24 parts of the fruit of Chinese wolfberry, 23 parts of Fructus Corni, Rhizoma Atractylodis Macrocephalae 24
Part, 22 parts of pueraria lobata, 16 parts of the root bark of white mulberry.
5. fat reducing according to claim 1 or 2 or 3 or 4 is depressured chrysanthemum tea, which is characterized in that the ginkgo biloba p.e
Extracting method be:It is crushed after ginkgo leaf is freeze-dried, 40-100 mesh sieve is crossed, by Ginkgo Leaf 2g in round-bottomed flask
In tested, 60-68% ethanol solutions 50ml mixing is added, refluxing extraction 2-3h, is filtered while hot under 60-65 DEG C of water-bath, filter
Slag carries out second extraction, collects filtrate, and the ethanol solution for being later 70-75% with volume fraction washs residue and filters, and merges 3
Secondary filtrate, by filtrate under 50-55 DEG C of water-bath spin concentration, obtain ginkgo biloba p.e.
6. a kind of production method of the decompression of the fat reducing as described in claim 1-5 is any chrysanthemum tea, which is characterized in that including following step
Suddenly:
S1, each raw material is weighed according to parts by weight;
S2, chrysanthemum, uncaria, the fruit of Chinese wolfberry, Fructus Corni, Rhizoma Atractylodis Macrocephalae, pueraria lobata, the root bark of white mulberry are mixed into input distilling kettle, addition accounts for distilling kettle
2/3 water, boiling 1-2h, filtering obtain filtrate and solid slag, and filtrate is concentrated and dried into medicinal extract, solid slag is dried, spare;
S3, the solid slag after step S2 drying is crushed, is uniformly mixed with medicinal extract, ginkgo biloba p.e, re-dry, sterilization, whole grain,
Small tea bag is made in pack packaging, you can.
7. production method according to claim 6, which is characterized in that sterilization is to disappear under ozonizer described in step S3
Poison sterilizing 1-2h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810286564.4A CN108477342A (en) | 2018-03-30 | 2018-03-30 | A kind of fat reducing decompression chrysanthemum tea and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810286564.4A CN108477342A (en) | 2018-03-30 | 2018-03-30 | A kind of fat reducing decompression chrysanthemum tea and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108477342A true CN108477342A (en) | 2018-09-04 |
Family
ID=63317671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810286564.4A Pending CN108477342A (en) | 2018-03-30 | 2018-03-30 | A kind of fat reducing decompression chrysanthemum tea and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108477342A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104719533A (en) * | 2015-03-13 | 2015-06-24 | 云南省林业科学院 | Dendrocalamus latiflorus, gingko and Pu'er instant tea and preparation method thereof |
CN105053410A (en) * | 2015-08-26 | 2015-11-18 | 蒋传中 | Medicinal compound chrysanthemum tea and preparation method thereof |
KR101627313B1 (en) * | 2015-12-17 | 2016-06-03 | 마성심 | Manufacturing method of yellow dye tea and yellow dye tea thereof |
-
2018
- 2018-03-30 CN CN201810286564.4A patent/CN108477342A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104719533A (en) * | 2015-03-13 | 2015-06-24 | 云南省林业科学院 | Dendrocalamus latiflorus, gingko and Pu'er instant tea and preparation method thereof |
CN105053410A (en) * | 2015-08-26 | 2015-11-18 | 蒋传中 | Medicinal compound chrysanthemum tea and preparation method thereof |
KR101627313B1 (en) * | 2015-12-17 | 2016-06-03 | 마성심 | Manufacturing method of yellow dye tea and yellow dye tea thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104435775B (en) | A kind of Traditional Chinese medicinal health-care wine and preparation method thereof | |
KR101294762B1 (en) | Functional soap and manufacturing method of it | |
KR101128564B1 (en) | The manufacturing process of lithospermum erythrorhizon soap controlled by vineger | |
CN106720787A (en) | A kind of hypoglycemic blood pressure depressing health tea and preparation method thereof | |
CN104921979A (en) | Plant shower gel | |
CN102389009B (en) | Health tea with whitening and beautifying effect | |
CN102771603B (en) | Red rhodobryum heart nourishing tea and preparation method thereof | |
CN103766905A (en) | Dendrobium candidum-chuzhou chrysanthemum health-care granule | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN105907458A (en) | Health-caring sesame oil suitable for people having hypertension, hyperglycemia and hyperlipidemia and preparation method of same | |
CN107494817A (en) | A kind of hypoglycemic tea | |
CN103621707A (en) | Health-care green tea capable of lowering blood pressure and production method thereof | |
CN106668294A (en) | Salvia miltiorrhiza leaf composite healthcare tea having efficacies for reducing blood glucose, reducing blood fat and lowering blood pressure and preparation method and use of salvia miltiorrhiza composite leaf healthcare tea | |
CN106727216A (en) | A kind of lavender sleeping facial mask and preparation method thereof | |
CN106579109A (en) | Citrus powder composition capable of neutralizing effect of alcoholic drinks and protecting liver, and preparation method of citrus powder composition | |
CN106035849A (en) | Blood-pressure-reducing health tea and preparation process thereof | |
CN102823696A (en) | Preparation method of composite gastrodia tuber and black garlic filled chocolate | |
CN102920807A (en) | Herb tea for lowering blood pressure | |
CN105831318A (en) | Polypeptide tea for blood glucose reduction and manufacturing method of polypeptide tea | |
CN108477342A (en) | A kind of fat reducing decompression chrysanthemum tea and preparation method thereof | |
CN1132606C (en) | Medicine for curing coronary heart disease with hypertension and its preparation process | |
CN104336286B (en) | A kind of Syringa pubescens health-care sweets with antihypertensive effect and preparation method thereof | |
CN104940524B (en) | It is a kind of to be used to treat drug of leucoderma and preparation method thereof | |
CN108208076A (en) | A kind of chocolate souffles and preparation method thereof | |
CN108159191A (en) | Composition, purposes and oral liquid of kidney and preparation method thereof are good in establishing-Yang |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180904 |
|
RJ01 | Rejection of invention patent application after publication |